These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37442267)

  • 21. Current Availability of Stem Cell-Based In Vitro Methods for Developmental Neurotoxicity (DNT) Testing.
    Fritsche E; Barenys M; Klose J; Masjosthusmann S; Nimtz L; Schmuck M; Wuttke S; Tigges J
    Toxicol Sci; 2018 Sep; 165(1):21-30. PubMed ID: 29982830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward a Better Testing Paradigm for Developmental Neurotoxicity: OECD Efforts and Regulatory Considerations.
    Sachana M; Shafer TJ; Terron A
    Biology (Basel); 2021 Jan; 10(2):. PubMed ID: 33498772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals.
    Crofton KM; Mundy WR; Lein PJ; Bal-Price A; Coecke S; Seiler AE; Knaut H; Buzanska L; Goldberg A
    ALTEX; 2011; 28(1):9-15. PubMed ID: 21311847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities.
    Smirnova L; Hogberg HT; Leist M; Hartung T
    ALTEX; 2014; 31(2):129-56. PubMed ID: 24687333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for harmonization of data collection and analysis of developmental neurotoxicity endpoints in regulatory guideline studies: Proceedings of workshops presented at Society of Toxicology and joint Teratology Society and Neurobehavioral Teratology Society meetings.
    Li AA; Sheets LP; Raffaele K; Moser V; Hofstra A; Hoberman A; Makris SL; Garman R; Bolon B; Kaufmann W; Auer R; Lau E; Vidmar T; Bowers WJ
    Neurotoxicol Teratol; 2017 Sep; 63():24-45. PubMed ID: 28757310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omnisphero: a high-content image analysis (HCA) approach for phenotypic developmental neurotoxicity (DNT) screenings of organoid neurosphere cultures in vitro.
    Schmuck MR; Temme T; Dach K; de Boer D; Barenys M; Bendt F; Mosig A; Fritsche E
    Arch Toxicol; 2017 Apr; 91(4):2017-2028. PubMed ID: 27722930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human Ntera2 cells as a predictive in vitro test system for developmental neurotoxicity.
    Stern M; Gierse A; Tan S; Bicker G
    Arch Toxicol; 2014 Jan; 88(1):127-36. PubMed ID: 23917397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Oligodendrocytes and Myelin In Vitro to Evaluate Developmental Neurotoxicity.
    Chesnut M; Hartung T; Hogberg H; Pamies D
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of the limitations and uncertainties of in vivo developmental neurotoxicity testing and assessment to identify the potential for alternative approaches.
    Paparella M; Bennekou SH; Bal-Price A
    Reprod Toxicol; 2020 Sep; 96():327-336. PubMed ID: 32781019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OECD/EFSA workshop on developmental neurotoxicity (DNT): The use of non-animal test methods for regulatory purposes.
    Fritsche E; Crofton KM; Hernandez AF; Hougaard Bennekou S; Leist M; Bal-Price A; Reaves E; Wilks MF; Terron A; Solecki R; Sachana M; Gourmelon A
    ALTEX; 2017; 34(2):311-315. PubMed ID: 28407175
    [No Abstract]   [Full Text] [Related]  

  • 31. Current status of developmental neurotoxicity: an industry perspective.
    Kaufmann W
    Toxicol Lett; 2003 Apr; 140-141():161-9. PubMed ID: 12676463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New approach methods to assess developmental and adult neurotoxicity for regulatory use: a PARC work package 5 project.
    Tal T; Myhre O; Fritsche E; Rüegg J; Craenen K; Aiello-Holden K; Agrillo C; Babin PJ; Escher BI; Dirven H; Hellsten K; Dolva K; Hessel E; Heusinkveld HJ; Hadzhiev Y; Hurem S; Jagiello K; Judzinska B; Klüver N; Knoll-Gellida A; Kühne BA; Leist M; Lislien M; Lyche JL; Müller F; Colbourne JK; Neuhaus W; Pallocca G; Seeger B; Scharkin I; Scholz S; Spjuth O; Torres-Ruiz M; Bartmann K
    Front Toxicol; 2024; 6():1359507. PubMed ID: 38742231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Per- and Polyfluoroalkyl Substances (PFAS)
    Carstens KE; Freudenrich T; Wallace K; Choo S; Carpenter A; Smeltz M; Clifton MS; Henderson WM; Richard AM; Patlewicz G; Wetmore BA; Paul Friedman K; Shafer T
    Chem Res Toxicol; 2023 Mar; 36(3):402-419. PubMed ID: 36821828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards in vitro DT/DNT testing: Assaying chemical susceptibility in early differentiating NT2 cells.
    Menzner AK; Abolpour Mofrad S; Friedrich O; Gilbert DF
    Toxicology; 2015 Dec; 338():69-76. PubMed ID: 26498558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for Developmental Neurotoxicity at the National Toxicology Program: The Future Is Here.
    Behl M; Ryan K; Hsieh JH; Parham F; Shapiro AJ; Collins BJ; Sipes NS; Birnbaum LS; Bucher JR; Foster PMD; Walker NJ; Paules RS; Tice RR
    Toxicol Sci; 2019 Jan; 167(1):6-14. PubMed ID: 30496580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes.
    Bal-Price A; Crofton KM; Leist M; Allen S; Arand M; Buetler T; Delrue N; FitzGerald RE; Hartung T; Heinonen T; Hogberg H; Bennekou SH; Lichtensteiger W; Oggier D; Paparella M; Axelstad M; Piersma A; Rached E; Schilter B; Schmuck G; Stoppini L; Tongiorgi E; Tiramani M; Monnet-Tschudi F; Wilks MF; Ylikomi T; Fritsche E
    Arch Toxicol; 2015 Feb; 89(2):269-87. PubMed ID: 25618548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of learning, memory, and attention in developmental neurotoxicity regulatory studies: synthesis, commentary, and recommendations.
    Vorhees CV; Makris SL
    Neurotoxicol Teratol; 2015; 52(Pt A):109-15. PubMed ID: 26526903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International STakeholder NETwork (ISTNET) for creating a developmental neurotoxicity testing (DNT) roadmap for regulatory purposes.
    Crofton K; Fritsche E; Ylikomi T; Bal-Price A
    ALTEX; 2014; 31(2):223-4. PubMed ID: 24794006
    [No Abstract]   [Full Text] [Related]  

  • 39. From the Cover: Developmental Neurotoxicants Disrupt Activity in Cortical Networks on Microelectrode Arrays: Results of Screening 86 Compounds During Neural Network Formation.
    Frank CL; Brown JP; Wallace K; Mundy WR; Shafer TJ
    Toxicol Sci; 2017 Nov; 160(1):121-135. PubMed ID: 28973552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation.
    Koch K; Bartmann K; Hartmann J; Kapr J; Klose J; Kuchovská E; Pahl M; Schlüppmann K; Zühr E; Fritsche E
    Front Toxicol; 2022; 4():816370. PubMed ID: 35295221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.